- $1.14bn
- $1.08bn
- $83.81m
NASDAQ RESUMED AT 10:46 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:40 AM
Brief: Iradimed Corporation Announces Q4 Earnings Per Share $0.26
Brief: IRadimed Resumed Shipments Of MRI Compatible Patient Vital Signs Monitoring Systems Into European Commission Markets
Brief: Iradimed Corp Executive Vice President Of Worldwide Sales & Marketing Terminated Existing Individual Written Stock Trading Plan
Brief: IRadimed Corp Reports Q3 Non-Gaap Earnings Per Share $0.23
Brief: IRadimed Resolves Warning Letter Related To Infusion Pump System
IRadimed Corp: Surges on beat-and-raise quarter
Brief: IRadimed Corporation Announces Second Quarter 2019 Financial Results
Brief: Iradimed Corp Names Leslie Mcdonnell As President And CEO
Brief: IRadimed Posts Q1 Non-GAAP Earnings Per Share $0.13
Brief: Iradimed Says On March 26, Co Entered Amendment To Supply Agreement With Fukoku Co., Ltd. Dated As Of Jan 26, 2014
Brief: Iradimed Sees Q1 2019 Revenue Of $8.3 Mln To $8.5 Mln
IRadimed Corp shares fall on expecting a drop in 2019 revenue
Brief: Iradimed Corp Sees Minor Impact To 2019 Revenue After Temporarily Suspending Shipments Of MRI Compatible Patient Vital Signs Monitoring Systems In Europe
Brief: Iradimed Reports Q3 GAAP Earnings Per Share $0.20
Brief: Iradimed Corp Announces Q3 2018 Financial Results
Brief: IRadimed Corp Q2 Non-GAAP Earnings Per Share $0.14
Corrected: BRIEF-IRadimed Corporation Q1 GAAP Earnings Per Share $0.07 (April 30)